Summary: Buoy Health utilizes artificial intelligence to provide users with personalized health assessments based on their symptoms. By asking a series of questions, the tool narrows down possible conditions and suggests next steps for care. This approach aims to make health information more accessible and actionable, guiding users to the right medical advice, services, or products.

Summary: WRDensity leverages artificial intelligence to provide a more consistent assessment of breast density during mammography screenings. It is designed to integrate seamlessly with RIS/PACS systems and has been trained on over 600,000 images from the Mallinckrodt Institute of Radiology. This tool aims to create uniformity in density assessment at the practice level, improving the accuracy of breast cancer screenings.

Summary: TeraRecon provides an advanced visualization and artificial intelligence (AI) platform designed to enhance medical imaging workflows. The platform integrates with existing systems to offer AI-driven insights and decision support across various specialties including radiology, cardiology, and neurology. It aims to improve patient care by accelerating time-to-treatment and enhancing diagnostic accuracy through the use of cutting-edge AI technologies.

Summary: Koios DS™ leverages artificial intelligence and machine learning to provide clinical decision support for the diagnosis of breast and thyroid cancer through ultrasound imaging. This software aims to improve diagnostic accuracy and efficiency, potentially leading to earlier detection and treatment. With FDA clearance and CE marking, Koios DS™ integrates into clinical workflows, offering a billable procedure that enhances both survival rates and workflow efficiency.

Summary: ECG-AI™ LEF by Anumana utilizes advanced AI algorithms to analyze electrocardiogram (ECG) data for the early detection of cardiovascular diseases, including low ejection fraction, which is indicative of heart failure. This tool is designed to aid physicians in identifying at-risk patients earlier, enabling timely intervention and potentially improving patient outcomes. Anumana's technology is built on a foundation of extensive electrophysiological data and validated through clinical research.

Summary: MAUI Imaging introduces an advanced ultrasound solution capable of imaging through obstacles such as bone, air, and metal, specifically designed for the brain. This FDA-cleared technology aims to revolutionize medical imaging by providing clear, real-time visuals for diagnosing and monitoring traumatic injuries, especially in environments where traditional imaging tools like CT scans are unavailable.

Summary: DEEPVESSEL FFR utilizes AI to perform non-invasive CT fractional flow reserve analysis, providing a physiological functional assessment of coronary arteries from coronary CT angiograms. This tool aims to minimize the need for invasive testing, enhance patient safety, and reduce the costs associated with cardiovascular care. It integrates seamlessly into clinical workflows, offering precise and comprehensive analysis to support decision-making in the management of coronary artery disease.

Summary: UltraSight offers AI-driven software that provides real-time guidance and quality assessment for healthcare professionals performing cardiac ultrasound. Designed to assist users regardless of their sonography proficiency, the tool enables the consistent performance of high-quality cardiac ultrasound across various settings, including clinics, community hospitals, and remote areas. This innovation aims to improve the accessibility, ease, and quality of cardiac imaging and diagnosis, facilitating more accurate and timely clinical decisions.

Summary: Hermia by Hermes Medical Solutions is a comprehensive, vendor-neutral software suite designed for nuclear medicine and molecular imaging. It integrates with all equipment and staff within a medical facility, aiming to optimize the potential of nuclear medicine departments. The software supports a wide range of clinical specialties, including advanced dosimetry tools, and offers scalability to meet future clinical needs.

Summary: QuPath offers tools for visualizing and analyzing complex biological images, such as whole slide images in pathology. It supports a wide range of image types and provides features for annotation, measurement, and automated analysis to facilitate research in bioimaging. Users can customize and extend its capabilities through scripting and plugins, making it adaptable to various research needs.

Summary: DERM (Deep Ensemble for the Recognition of Malignancy) is a Class III CE marked AI as a Medical Device (AIaMD) designed to improve skin cancer triage. It integrates with teledermatology platforms to accurately triage patients with non-cancerous lesions away from cancer pathways, optimizing dermatologist capacity for the most needed cases. This technology aims to enhance patient outcomes by ensuring timely and accurate skin cancer care.

Summary: DovaVision offers an AI-driven solution for assessing disease severity in Ulcerative Colitis (UC) through endoscopic analysis. This tool leverages deep data analysis to provide clinicians and researchers with actionable insights, aiming to improve the accuracy of UC severity assessments. Currently available for research and clinical trials, DovaVision integrates into clinical workflows to support informed decision-making.

Summary: Ultrarad AI provides a suite of AI-powered diagnostic tools designed to improve the accuracy and efficiency of radiology interpretations. The platform includes features like Doppler Interpretations, Calculators, and TAARA, an intelligent radiology assistant, which together support a wide range of radiological examinations and workflows. These tools aim to save time for radiologists and improve patient outcomes by enabling more precise and faster diagnoses.

Summary: AssureMDx is a urine-based test designed to help physicians identify patients with hematuria who are at increased risk for bladder cancer, facilitating timely referral to urology for further clinical evaluation. The test evaluates genomic changes associated with bladder cancer, including DNA methylation status and somatic mutation status of specific genes, to stratify patients by risk and potentially avoid unnecessary invasive procedures for those at low risk.

Summary: STAGE is a platform designed to improve the quality of MRI images, specifically focusing on brain scans. It enables MRI machines to produce clearer images and gather quantitative data without requiring additional scan time. In fact, STAGE can reduce MRI brain protocol times by up to 30%, increasing daily scan capacity and providing more detailed images for better diagnostic and treatment decisions.

Summary: The IB Clinic Neuro-Oncology Application Suite offers a comprehensive set of tools for the analysis of physiological imaging in neuro-oncology. It includes applications for perfusion MRI and CT analysis, MR image registration, and subtraction for enhanced comparison of images. This suite is designed to support diagnosis, pre-surgical planning, treatment response monitoring, and follow-up, providing clinicians and researchers with reliable and proven tools for advanced MRI analysis.

Summary: QyScore® is an AI-powered neuroimaging software platform designed to assist healthcare professionals in the diagnosis and monitoring of central nervous system (CNS) diseases. It automates the process of labeling, visualizing, and quantifying brain structures and lesions from MR images, offering an objective layer of precision to clinical care decisions. The tool is FDA-cleared and CE-marked, supporting its use in clinical settings for a more accurate and reliable diagnosis of CNS disorders.

Summary: Stratipath Breast is an AI-powered tool designed for the prognostic risk profiling of breast cancer, capable of identifying patients with varying risks of disease progression. It analyzes cancer tissue to provide insights into the likelihood of disease advancement, offering a quicker and less costly alternative to gene expression testing. This tool is integrated into clinical workflows, providing results that can significantly impact treatment decisions.

Summary: Heartflow One leverages coronary CTA (CCTA) scans to generate detailed, dynamic 3D models of a patient's heart, providing insights into coronary artery disease (CAD). This technology aims to improve the accuracy of CAD diagnosis and treatment by offering tools for assessing anatomy and physiology, quantifying and characterizing plaque, and evaluating blood flow. It supports personalized treatment pathways, aiming to reduce unnecessary procedures and improve patient outcomes.

Summary: Signatera is a highly sensitive, personalized MRD test that detects circulating tumor DNA (ctDNA) in the blood. It is tailored to the unique genetic makeup of an individual's tumor, allowing for the early detection of cancer recurrence and the monitoring of treatment response. This non-invasive test offers a way to identify minimal residual disease with high precision, providing valuable insights for personalized treatment planning.

Summary: IB Lab ZOO is an AI-supported modular software platform designed for the automated, objective, and standardized analysis of musculoskeletal (MSK) medical images. It offers a suite of tools for diagnosing and managing various MSK conditions by extracting key disease parameters from medical images, thereby aiding in the prevention and treatment of these conditions.

Summary: Virtual Nodule Clinic (VNC) by Optellum is designed to enhance the early diagnosis of lung cancer by discovering, tracking, and assessing the risk of malignancy in lung nodule patients. It integrates seamlessly with existing EHR and PACS systems, utilizing the FDA-cleared and UKCA / CE-marked Optellum Lung Cancer Prediction (LCP) AI. This technology enables healthcare providers to automatically prioritize lung nodule patients, potentially finding more lung cancer cases earlier and reducing time to diagnosis.

Summary: Masimo SET® Pulse Oximetry offers precise measurements of oxygen saturation levels in the blood, ensuring accuracy regardless of a patient's skin pigmentation. This technology addresses the critical need for reliable oximetry readings in diverse patient populations, helping clinicians make informed decisions based on accurate data. Its ability to deliver consistent results across various skin tones enhances patient care and safety.

Summary: MammoScreen by Therapixel utilizes artificial intelligence to analyze mammography images, aiming to improve the accuracy and efficiency of breast cancer detection. This technology supports radiologists by identifying and highlighting areas of concern within mammograms, potentially speeding up diagnosis and treatment planning. Its adoption by healthcare providers like the Mayo Clinic underscores its effectiveness in clinical settings.

Summary: Aidar Health focuses on creating clinically validated software and breath-and saliva-based biosensors. These technologies are designed to deliver evidence-based digital interventions across therapeutic areas such as respiratory, renal, infectious, cardiovascular, and oncology. The goal is to empower personalized care and enable aging in place by reimagining disease management and digital medicine.

Summary: LumineticsCore® is a groundbreaking AI diagnostic tool specifically designed for the detection of diabetic retinopathy directly at the point-of-care, enabling immediate results without the need for a physician's evaluation. This tool integrates seamlessly into clinical workflows, offering a rapid diagnosis within 30 seconds of image submission, thereby facilitating early detection and intervention. Its FDA clearance underscores its reliability and effectiveness in improving patient outcomes by closing care gaps in diabetes management.

Summary: SkinVision is a mobile application designed to help users assess and monitor their skin for signs of cancer. By using advanced AI technology and the expertise of dermatologists, the app evaluates photos of skin spots and provides risk assessments. It aims to facilitate early detection of skin cancer, offering users guidance on whether a professional medical consultation is advisable.

Summary: Imbio offers a suite of AI-driven tools that transform standard medical imaging into detailed visual maps and quantitative reports of patient conditions. These tools are designed to assist physicians and health systems in the early detection, diagnosis, treatment, and management of chronic lung and cardiothoracic diseases. By leveraging advanced image analysis algorithms, Imbio aims to improve patient outcomes through more personalized medicine.

Summary: cvi42 is an AI-powered platform designed to enhance cardiovascular imaging analysis. It offers clinically validated tools that automate diagnosis processes and integrate seamlessly into clinical workflows, aiming to improve accuracy and efficiency in patient care. The platform supports a range of cardiovascular imaging modalities, providing easy-to-use tools for physicians and technicians.

Summary: Seegene Technologies offers a comprehensive range of molecular diagnostic solutions, focusing on real-time PCR assays for detecting respiratory, gastrointestinal, sexually transmitted infections, and more. Their products are designed for high specificity and sensitivity, utilizing proprietary technologies such as MUDT™, TOCE™, and DPO™ to enable multiplex detection and streamlined workflows in laboratory settings.

Summary: aview LCS Plus is an advanced diagnostic tool that leverages artificial intelligence to simultaneously detect and analyze pulmonary nodules, emphysema, and coronary artery calcification from chest CT scans. This comprehensive solution aids healthcare professionals in diagnosing major chest diseases efficiently, enhancing patient care by providing accurate and rapid analysis.

Summary: Nanox.ARC is an FDA-cleared digital imaging system that leverages multi-source 3D tomosynthesis technology to provide advanced radiographic visualization. This system aims to enhance diagnostic imaging capabilities, offering high-resolution images at lower doses compared to traditional methods. It's designed to integrate seamlessly into healthcare workflows, improving patient care through more accurate and efficient diagnostic processes.

Summary: RADLogics' AI platform automates the analysis of DICOM data from CT and X-ray scans, providing automatic detection, measurements, and key images. The platform is designed to integrate seamlessly into existing workflows, enhancing radiologists' productivity and patient outcomes. It includes FDA-cleared applications, supporting a rapid and accurate diagnosis process.

Summary: ThinkSono Guidance is an AI-driven software that enables healthcare professionals, regardless of their prior experience with ultrasound, to perform proximal compression ultrasound exams for the detection of deep vein thrombosis (DVT). This tool is designed to integrate seamlessly into the clinical workflow, significantly reducing the time required for DVT diagnosis from hours to just 15 minutes, thereby streamlining the DVT clinical pathway and improving patient care efficiency.

Summary: Us2.v2 is an AI-powered tool designed to automate the analysis and reporting of echocardiography, supporting real-time 2D and Doppler interpretation. It aims to simplify and speed up the process of echocardiographic evaluation with zero clicks, providing complete reports that are interchangeable with expert analysis. The tool can connect to any ultrasound device, making it accessible for use in various clinical settings.

Summary: SyMRI by SyntheticMR AB offers a suite of software solutions designed to optimize Magnetic Resonance Imaging (MRI) workflows. It enables the generation of multiple, adjustable contrast images, tissue segmentations, and quantitative data, including unique myelin measurements, from a single 5-minute scan. This technology supports faster diagnosis and monitoring of disease progression, offering objective data for decision-making in clinical settings.

Summary: GeneDx specializes in genetic testing and diagnostic services to identify rare and common genetic disorders. Utilizing advanced genomic technologies, the company offers a comprehensive suite of tests, including exome and genome sequencing, to healthcare providers and patients. These tests are designed to deliver clinically actionable results, enabling faster and more precise diagnoses for a wide range of genetic conditions.

Summary: EarliPoint leverages advanced technology to analyze the looking behavior of children as they watch short video scenes of social interactions. This FDA-authorized tool captures and analyzes subtle visual engagement patterns that are imperceptible to the human eye, providing clinicians with robust data to diagnose autism with greater confidence and objectivity. The tool aims to facilitate early diagnosis and assessment of autism by studying social-visual engagement.

Summary: EyeArt is an FDA-cleared AI system designed for the autonomous detection of diabetic retinopathy (DR), including both more than mild and vision-threatening stages. It enables in-clinic, real-time DR screening by analyzing retinal images captured with specific camera models. The system provides immediate results, making it possible for primary care, diabetes centers, and optometric offices to identify referable DR patients during regular exams without the need for human grading.

Summary: The DermTech Melanoma Test is a genomic test that utilizes non-invasive Smart Stickers to collect skin cells from melanocytic lesions that meet specific criteria. It analyzes genomic markers associated with melanoma to differentiate between benign and higher-risk lesions. With a 99% negative predictive value, the test provides a high level of confidence in ruling out melanoma, offering an objective and actionable alternative to traditional biopsy methods.

Summary: The Galaxy System by Noah Medical is a medical robotics platform equipped with TiLT+ Technology™, aimed at enhancing diagnostic yield in interventional pulmonology. It addresses CT-to-body divergence with real-time navigation updates and guidance, including an augmented fluoro feature for locating non-visual lesions. The system also features a single-use bronchoscope to reduce cross-contamination risks and streamline procedural efficiency.

Summary: ArtFun+ is a clinically validated medical device software developed by Imageens for the measurement of MRI imaging biomarkers, which are significant predictors of cardiovascular diseases and mortality. The software has achieved class 2a approval under the EU MDR, making it a reliable tool for cardiologists and clinics to use in cardiovascular check-ups and prevention strategies by providing personalized reports on cardiovascular age and early detection of cardiovascular diseases.

Summary: RBfracture™ is designed to assist healthcare professionals by automatically detecting traumas such as fractures, dislocations, lipohemarthrosis, and effusions in radiology images. Utilizing AI technology, it aims to improve the accuracy, specificity, and sensitivity of trauma detection, boasting a median processing time of just 13 seconds per exam. This tool is trained on emergency data from over 1,300 hospitals worldwide, offering a significant reduction in missed fracture rates.

Summary: Heuron offers AI-driven diagnostic aids for central nervous system disorders, including Parkinson's disease, Alzheimer's disease, stroke, and brain metastasis. Utilizing advanced AI models that incorporate clinical specialists' diagnostic insights, Heuron's software aims to simplify complex diagnostic challenges. The tools provide features such as identification of nigrostriatal degeneration, volumetric analysis, and early detection of brain diseases through MRI and CT scans.

Summary: NeuroQuant is a software tool designed for the automated segmentation and volumetric analysis of brain images. It aids clinicians in the diagnosis and monitoring of neurological conditions by providing quantitative data on brain structures. This tool is integrated into clinical workflows to enhance the accuracy and efficiency of brain assessments, supporting earlier diagnosis and treatment planning.

Summary: icobrain is an AI-driven, FDA-cleared software designed to assist radiologists and neurologists in the diagnosis and monitoring of neurological conditions through the analysis of brain MRI scans. It provides quantitative data and visualizations that highlight changes over time, aiding in the detection and quantification of disease progression or treatment response. This tool integrates seamlessly into clinical workflows, offering a data-driven approach to neurological care.

Summary: Quantib Prostate supports radiologists by automating the segmentation of the prostate and suspicious regions of interest (ROI) in MRI scans. It integrates PSA density calculations and provides PI-RADS scoring support, aiming to enhance the accuracy and efficiency of prostate MRI readings. This tool is designed to fit seamlessly into existing radiology workflows, offering a streamlined approach to prostate cancer diagnosis.

Summary: Caris Life Sciences offers a suite of molecular diagnostics and profiling services designed to help oncologists make more informed treatment decisions. By analyzing a patient's cancer at the molecular level through whole exome and whole transcriptome sequencing, Caris delivers detailed insights into the genetic makeup of tumors. This approach enables personalized therapy selection, disease detection, and treatment monitoring, leveraging one of the world's largest databases of molecular and clinical outcomes.

Summary: ClearRead CT leverages deep learning AI technology to provide radiologists with an unobstructed view of the chest, enhancing the detection and measurement of nodules and quantification of coronary artery calcification (CAC). Designed for efficiency and accuracy, it integrates with radiology reports, comparing findings with prior exams and detecting 29% more nodules while reading 36% faster.

Summary: FoundationOne CDx is a next-generation sequencing based in vitro diagnostic test designed for advanced cancer patients with solid tumors. It utilizes FFPE tissue samples to analyze 324 genes as well as genomic signatures, helping to identify the genomic alterations driving a patient's cancer. This information can match patients with relevant targeted therapies, immunotherapies, and clinical trial options, providing a personalized approach to cancer treatment.